2.9 C
New York
Wednesday, February 8, 2023

What Are The Chances Of Relay Therapeutics Inc. (NASDAQ: RLAY) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Relay Therapeutics Inc. (RLAY) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.21, or 1.02%, to $20.89. The Relay Therapeutics Inc. has recorded 131,416 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Stocks Info

As a NASDAQ listed company, RLAY falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $20.68 and fluctuated between $21.21 as its day high and $20.36 as its day low. The current market capitalization of Relay Therapeutics Inc. is $2.42B. A total of 1.17 million shares were traded on the day, compared to an average of 1.28M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, RLAY has seen 4 BUY and 11 SELL insider trades, representing the acquisition of 50,000 and the disposition of 55,812 shares. Over the last 12 months, there were 36 BUYs and 61 SELLs from insiders. Insiders purchased 578,017 shares during that period but sold 468,150.

In the most recent transaction, Adams Brian sold 9,994 shares of RLAY for 20.00 per share on Jan 12. After the transaction, the Chief Legal Officer now owns 51,531 company shares. In a previous transaction on Dec 27, Catinazzo Thomas sold 445 shares at 14.49 per share. RLAY shares that Chief Financial Officer owns now total 50,231.

Among the insiders who sold shares, Bergstrom Donald A disposed of 980 shares on Dec 27 at a per-share price of $14.49. This resulted in the President, R&D holding 85,886 shares of RLAY after the transaction. In another insider transaction, Adams Brian sold 295 shares at $14.49 per share on Dec 27. Company shares held by the Chief Legal Officer now total 61,525.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for RLAY in the last 3 months, the mean price target is $39.56 with high estimates of $45.00 and low estimates of $23.00. In terms of 52-week highs and lows, RLAY has a high of $35.36 and a low of $12.65.

As of this writing, RLAY has an earnings estimate of -$0.71 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.61 per share and a lower estimate of -$0.76. The company reported an EPS of -$0.57 in the last quarter, which was 8.10% higher than expectations of -$0.62.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 10 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Hold with a score of 4.50. A total of 9 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles